TH
The startup has developed a heart valve replacement system specifically designed for the treatment of severe tricuspid regurgitation, utilizing a one-step procedure with a physiologically sized valve to manage right ventricular load. This technology addresses the anatomical challenges associated with tricuspid valve replacement, providing patients with an effective treatment option for their heart conditions.
Updated 3 months ago
Funding
$12.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
L
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a heart valve replacement system specifically designed for the treatment of severe tricuspid regurgitation, utilizing a one-step procedure with a physiologically sized valve to manage right ventricular load. This technology addresses the anatomical challenges associated with tricuspid valve replacement, providing patients with an effective treatment option for their heart conditions.